SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go?
PFE 25.88+1.5%3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: BigKNY3 who wrote (7630)5/7/1999 11:41:00 PM
From: Mkilloran  Read Replies (2) of 9523
 
BigKny3...tell Smith Barney to look at the UK Sweden and Canada where a marketing program and a sales force are inplace to sell MUSE.

They will get a whole new view of how MUSE can capture a larger percent of the ED market place.

Also Smith Barney neglected to include Alibra the next generation product from Vivus which will be marketed to a larger portion of the ED population with less side effects than MUSE.

Phase III FDA testing is expected to be completed in Sept 99 and you can expect Alibra to be selling in the 2000 alongside MUSE.

Smith Barney is pre occupied with Vasomax.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext